BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1606842)

  • 1. Cardiac effects of different eyedrop preparations of timolol in rabbits.
    Järvinen K; Urtti A
    Curr Eye Res; 1992 May; 11(5):469-73. PubMed ID: 1606842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration and long-term efficacy of phenylephrine-induced reduction in the systemic absorption of ophthalmic timolol in rabbits.
    Järvinen K; Urtti A
    J Ocul Pharmacol; 1992; 8(2):91-8. PubMed ID: 1506759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single dose of three different ophthalmic beta-blockers antagonizes the chronotropic effect of isoproterenol in healthy volunteers.
    Berlin I; Marcel P; Uzzan B; Millon D; Le Hoang P; Puech AJ
    Clin Pharmacol Ther; 1987 Jun; 41(6):622-6. PubMed ID: 2884059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of epinephrine pretreatment and solution pH on ocular and systemic absorption of ocularly applied timolol in rabbits.
    Kyyrönen K; Urtti A
    J Pharm Sci; 1990 Aug; 79(8):688-91. PubMed ID: 2231330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraocular pressure reduction and systemic absorption of timolol after administration of one side-coated inserts in rabbits.
    Saettone MF; Chetoni P; Cappanera L; Conte U; Finne U; Järvinen K; Salivirta J; Urtti A
    J Ocul Pharmacol; 1993; 9(1):1-12. PubMed ID: 8463729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic epinephrine, phenylephrine, and pilocarpine affect the systemic absorption of ocularly applied timolol.
    Urtti A; Kyyrönen K
    J Ocul Pharmacol; 1989; 5(2):127-32. PubMed ID: 2754297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and intraocular pressure lowering effect of timolol preparations in rabbit eyes.
    Chiang CH; Ho JI; Chen JL
    J Ocul Pharmacol Ther; 1996; 12(4):471-80. PubMed ID: 8951683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalaprilat and enalapril maleate eyedrops lower intraocular pressure in rabbits.
    Loftsson T; Thorisdóttir S; Fridriksdóttir H; Stefánsson E
    Acta Ophthalmol; 2010 May; 88(3):337-41. PubMed ID: 19432862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular responses to metipranolol and timolol eyedrops in healthy volunteers.
    Bacon PJ; Brazier DJ; Smith R; Smith SE
    Br J Clin Pharmacol; 1989 Jan; 27(1):1-5. PubMed ID: 2565117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchial beta-adrenoceptor blockade following eyedrops of timolol and its isomer L-714,465 in normal subjects.
    Richards R; Tattersfield AE
    Br J Clin Pharmacol; 1985 Nov; 20(5):459-62. PubMed ID: 2866789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans.
    Urtti A; Rouhiainen H; Kaila T; Saano V
    Pharm Res; 1994 Sep; 11(9):1278-82. PubMed ID: 7816756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular and cardiac beta-antagonism by timolol prodrugs, timolol and levobunolol.
    Potter DE; Shumate DJ; Bundgaard H; Lee VH
    Curr Eye Res; 1988 Aug; 7(8):755-9. PubMed ID: 2903009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the systemic cardiovascular and bronchial effects of beta-blocking eyedrops. Value of isoprenaline and carbachol tests. Therapeutic consequences].
    Sirbat D; Kohler C; George JL; Mayeux D; Grilliat JP
    Ophtalmologie; 1988; 2(3):213-8. PubMed ID: 3247170
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.
    Korte JM; Kaila T; Saari KM
    Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):430-5. PubMed ID: 12107508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic differences between ocular inserts and eyedrops.
    Friedrich SW; Saville BA; Cheng YL; Rootman DS
    J Ocul Pharmacol Ther; 1996; 12(1):5-18. PubMed ID: 8925396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timolol eyedrop-induced severe bronchospasm.
    Ostergaard Laursen S; Bjerrum P
    Acta Med Scand; 1982; 211(6):505-6. PubMed ID: 7113767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.
    Le Jeunne C; Munera Y; Hugues FC
    Clin Pharmacol Ther; 1990 May; 47(5):578-83. PubMed ID: 1971539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular drug interactions involving topically applied timolol in the pigmented rabbit.
    Luo AM; Sasaki H; Lee VH
    Curr Eye Res; 1991 Mar; 10(3):231-40. PubMed ID: 2044391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics and kinetics of ophthalmic timolol.
    Affrime MB; Lowenthal DT; Tobert JA; Shirk J; Eidelson B; Cook T; Onesti G
    Clin Pharmacol Ther; 1980 Apr; 27(4):471-7. PubMed ID: 7357805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.